The ZIVOLABS journal

Things worth knowing — before, during, after.

Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.

Browse the full article library

Results

Showing 112 of 104
Compare medications· 6 min

What's the difference between Ozempic and a generic semaglutide?

Same active molecule, but branded products are quality-assured and traceable. Indian generics/biosimilars are emerging; until widely approved, stick to licensed branded pens.

3 Feb 2026
Compare medications· 5 min

Which GLP-1 is best for non-diabetics?

Wegovy (semaglutide) and Mounjaro (tirzepatide) are the weight-focused choices for non-diabetics meeting BMI criteria. A doctor picks based on goals and tolerance.

19 Dec 2024
Compare medications· 5 min

Is GLP-1 better than metformin for weight loss?

For weight loss, clearly yes — metformin gives only modest loss. They're often combined for diabetes, where each adds value.

18 Dec 2024
Compare medications· 6 min

Is oral or injectable GLP-1 better?

Injectable is more potent and convenient (weekly, no fasting); oral (Rybelsus) avoids needles but needs strict empty-stomach dosing and gives milder results.

17 Dec 2024
Compare medications· 5 min

What is the best GLP-1 for PCOS?

Both semaglutide and tirzepatide work well for PCOS by improving insulin resistance. Choice depends on goals, cost and tolerance, often alongside metformin.

16 Dec 2024
Compare medications· 5 min

What is the best GLP-1 for someone just starting out?

There's no universal 'best' — your doctor matches the molecule to your goal, budget and health. Many start on semaglutide; tirzepatide suits higher weight-loss targets.

15 Dec 2024
Compare medications· 5 min

What is the cheapest GLP-1 in India?

Oral semaglutide (Rybelsus) is usually the most affordable, with older options like liraglutide or dulaglutide variable. The cheapest injectable depends on dose and pharmacy.

14 Dec 2024
Compare medications· 6 min

Which GLP-1 causes the most weight loss?

In trials, tirzepatide (Mounjaro) produced the most (~20%), ahead of semaglutide (Wegovy/Ozempic, ~15%). Your own response, diet and dose still matter most.

13 Dec 2024
Compare medications· 6 min

Which GLP-1 has the fewest side effects?

Side effects are broadly similar across the class and depend more on how slowly you titrate than the brand. Some find tirzepatide's nausea milder; individual response varies.

12 Dec 2024
Compare medications· 5 min

GLP-1 vs Orlistat (fat blocker): which works better?

Orlistat blocks some dietary fat absorption, giving modest weight loss but unpleasant gut side effects. GLP-1 is more effective and generally better tolerated.

7 Oct 2024
Compare medications· 5 min

GLP-1 vs just eating less (willpower): which works better?

Willpower fights your hormones, which is why most diets fail long-term. GLP-1 lowers the hunger signal itself, making 'eating less' feel possible rather than a constant battle.

6 Oct 2024
Compare medications· 5 min

GLP-1 vs phentermine / older diet pills: which works better?

Older appetite suppressants act on the nervous system, can't be used long-term, and have more cardiovascular caution. GLP-1 works on gut-brain hormones and is suitable for long-term use.

5 Oct 2024
Page 1Next →
ZIVOLABS prescription GLP medication — vial (weekly injection) and bottle (daily oral dissolving tablets)
Now accepting patients

Not a diet. Not a gym plan.
Medical science. Finally in India.

  • Available as weekly injection or daily tablets
  • Around 15% average weight loss in major GLP‑1 trials — results vary*
  • Unlimited 24/7 support from our care team
  • Start with a ₹499 doctor consultation — refunded if you’re not eligible
  • Medication & ongoing care quoted separately — price shown before you pay
Am I qualified?
Takes 5 minutes. No commitment required.
NMC-registered doctors DCGI-approved medication Licensed pharmacy delivery
*Average weight loss seen in published GLP-1 RA trials over 68 weeks. Individual results vary. Read the medical disclaimer.